Reproduction  
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS  

Reproduction (2007) 134 615-623
DOI: 10.1530/REP-06-0369
Copyright © 2007 Society for Reproduction and Fertility
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gnanalingham, M G
Right arrow Articles by Symonds, M E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gnanalingham, M G
Right arrow Articles by Symonds, M E

RESEARCH

Nutritional manipulation between early to mid-gestation: effects on uncoupling protein-2, glucocorticoid sensitivity, IGF-I receptor and cell proliferation but not apoptosis in the ovine placenta

M G Gnanalingham, P Williams, V Wilson, J Bispham, M A Hyatt, A Pellicano, H Budge, T Stephenson and M E Symonds

Institute of Clinical Research, Centre for Reproduction and Early Life, University of Nottingham, Nottingham NG7 2UH, UK

Correspondence should be addressed to M E Symonds at Academic Division of Child Health, School of Human Development, University Hospital, Nottingham NG7 2UH, UK; Email: michael.symonds{at}nottingham.ac.uk


    Abstract
 Top
 Abstract
 Introduction
 Results
 Discussion
 Materials and Methods
 Acknowledgements
 References
 
In sheep, modest maternal nutrient restriction (NR) over the period of rapid placental growth restricts placentome growth and results in offspring in which glucocorticoid action is enhanced. Therefore, this study investigated the placental effects of early to mid-gestational NR on glucocorticoid receptor (GR), 11ß-hydroxysteroid dehydrogenase type 2 (11ßHSD2), uncoupling protein-2 (UCP2), and IGF type-I receptor (IGF-IR) mRNA abundance together with cell proliferation and apoptosis as determined histologically, and the mitochondrial proteins voltage-dependent anion channel and cytochrome c that are involved in apoptosis. Placenta was sampled at 80 and 140 days gestation (dGA; term ~147 dGA). NR was imposed between 28 and 80 days gestation when control and nutrient-restricted groups consumed 150 or 60% respectively of their total metabolizable energy requirements. All mothers were then fed to requirements up to term. Total fetal placentome weights were decreased by NR at 80 dGA but were heavier at 140 dGA following 60 days of nutritional rehabilitation. GR and UCP2 mRNA abundance increased whilst 11ßHSD2 mRNA decreased with gestational age. NR persistently up-regulated GR and UCP2 mRNA abundance. 11ßHSD2 mRNA was reduced by NR at 80 dGA but increased near to term. IGF-IRmRNA abundance was only decreased at 80 dGA. Placental apoptosis and mitochondrial protein abundance were unaffected by NR, whereas cell proliferation was markedly reduced. In conclusion, placental UCP2 and local glucocorticoid action are affected by the gestational nutritional status and may result in the offspring showing enhanced glucocorticoid sensitivity, thereby predisposing them to disease in later life.


    Introduction
 Top
 Abstract
 Introduction
 Results
 Discussion
 Materials and Methods
 Acknowledgements
 References
 
Maternal nutrition is a major factor determining placental growth and development which in turn can have a strong influence on nutrient supply to the fetus (McMillen & Robinson 2005). Importantly, the impact of a reduction in maternal food intake at defined stages of pregnancy is not confined to the fetal period but can extend well into later life (Barker 2001, McMillen & Robinson 2005, Symonds et al. 2005). In the sheep, like the human, the period of pregnancy in which placental growth is greatest is from the time of implantation (or attachment in sheep) to around mid-gestation (Ehrhardt & Bell 1995). Ovine placental mass peaks at ~80 days gestation (Ehrhardt & Bell 1995) and is followed by marked change in its structural properties and conformation (Stegmann 1974). During this period, maternal nutrient restriction (NR; i.e. ~50%) has significant effects on placental growth and morphology (Clarke et al. 1998, Heasman et al. 1998) and causes a reduction in the mean weight of individual placentomes (Clarke et al. 1998), but the mechanism mediating this response has not been established. These adaptations within the placenta occur in conjunction with a reduced potential capacity to inactivate maternal cortisol through the enzyme 11ß-hydroxysteroid dehydrogenase (11ßHSD) type 2 (Whorwood et al. 2001), which itself may be in response to a decrease in maternal plasma cortisol (Bispham et al. 2003). Local tissue glucocorticoid hormone action is, however, regulated by expression of the glucocorticoid receptor (GR, type 2) and isoforms of 11ßHSD at the level of gene transcription (Bamberger et al. 1996). 11ßHSD type 1 (11ßHSD1) acts as an 11-oxoreductase to catalyze the conversion of cortisone to bioactive cortisol, thereby amplifying glucocorticoid action. Conversely, 11ßHSD type 2 (11ßHSD2) acts as an 11-dehydrogenase, catalyzing the inactivation of cortisol to cortisone, maintaining the specificity of the mineralocorticoid receptor for aldosterone (Stewart & Krozowski 1999). One aim of our study was, therefore, to determine whether glucocorticoid action within the placenta may be permanently reset following maternal NR. Glucocorticoids also have an important role in regulating uncoupling protein (UCP) abundance in the mitochondria of the fetus and newborn (Gnanalingham et al. 2006) but the extent to which this may extend to the placenta is currently unknown.

UCP2 has the most widespread tissue abundance and is present in the uterus of mice (Pecquer et al. 2001, Rousset et al. 2003). Its function remains a subject of intense debate (Stuart et al. 2001), but the abundance of UCP2 mRNA and/or protein has been shown to be developmentally regulated in both the lung and adipose tissue of sheep where one postulated role includes the regulation of apoptosis (Voehringer et al. 2000). In both these tissues, the abundance of UCP2 mRNA and protein is strongly influenced by the current and the past nutritional states (Mostyn et al. 2003, Gnanalingham et al. 2005a, 2005c). It is currently not known whether UCP2 is present in the placenta nor whether it is developmentally controlled or nutritionally responsive in utero. Therefore, an extension of our study was to determine whether UCP2 is present in the ovine placenta and if it is developmentally regulated. Other important mitochondrial proteins whose function is related to UCP2 include voltage-dependent anion channel (VDAC; Voehringer et al. 2000) located in the outer mitochondrial membrane (Colombini 1979). VDAC along with UCP2 (Voehringer et al. 2000) could be responsible for the release of cytochrome c from the intermembrane space, a process that has been implicated in the chain of events culminating in apoptosis (Crompton 1999). Placenta of clinically compromised pregnancies shows increased rates of apoptosis (Huppertz & Herrler 2005), but the extent to which apoptosis is enhanced by maternal NR has not been examined. We therefore aimed to determine not only the effect of maternal food intake on apoptosis but also the cellular location of VDAC and cytochrome c in the placenta.

Maternal dietary manipulation in early pregnancy results in a number of endocrine adaptations that may potentially impact on placental function. These include a reduction in the plasma concentrations of a range of maternal metabolic hormones including cortisol, thyroid hormones, insulin-like growth factor (IGF)-I, and insulin (Bispham et al. 2003, Symonds et al. 2007). A reduction in placental IGF type-I receptor (IGF-IR) is associated with intrauterine growth retardation (Reid et al. 2002, Laviola et al. 2005). The extent to which the same effect on the IGF-IR may result from changes in maternal nutrition is unknown and was a further aim of the present study. In order to achieve the aims of the study, placenta was sampled from control and nutritionally manipulated singleton-bearing sheep at:

  1. 80 days gestation, coincident with the peak in placental weight and following ~50 days of maternal NR.
  2. 140 days gestation, near to term (~147 days), following ~60 days of nutritional rehabilitation.


    Results
 Top
 Abstract
 Introduction
 Results
 Discussion
 Materials and Methods
 Acknowledgements
 References
 
Total weight of the fetal component of the placenta was decreased by early to mid-gestational NR at 80 days gestation compared with controls (C 507.8 ± 64.4; NR, 326.2 ± 20. 3 g (P<0.05)), but were heavier at 140 days gestation following 60 days of nutritional rehabilitation (C 183.6 ± 9.6; NR, 364.4 ± 21. 3 g (P<0.05)). Fetal weights were not different between groups at either gestational age, but near-term NR fetuses possessed more perirenal adipose tissue than controls (C 19.2 ± 1.9; NR 23.2 ± 1.4 g (P<0.05)) and had larger kidneys (C 16.5 ± 2.1; NR 20.3 ± 1.2 g (P<0.05)). There were no differences in weights between groups with respect to all the other major organs sampled (data not shown).

UCP2, GR, and 11ßHSD2 mRNA were all detected in the fetal placentome at 80 and 140 days gestation (Fig. 1A–CGo). UCP2 and GR mRNA abundance increased (P<0.01) with gestational age and were further raised, compared with controls (P<0.01), by early to mid-gestational NR (Fig. 1A and BGo). Interestingly, 11ßHSD2 mRNA abundance was lower (P<0.01) in the placenta of NR compared with control mothers at 80 days gestation (Fig. 1CGo). It then only decreased with gestational age in controls with the result that by 140 days gestation 11ßHSD2 mRNA abundance was significantly greater in placenta sampled from NR mothers compared with controls. Finally, irrespective of maternal diet and gestational age UCP2 and GR mRNA abundance were positively correlated (Fig. 2Go). IGF-IR mRNA abundance was decreased at 80 days gestation by NR, although by 140 days gestation this effect was negated by refeeding (Fig. 3Go).


Figure 1
View larger version (19K):
[in this window]
[in a new window]

 
Figure 1 Effect of early to mid-gestational maternal nutrient restriction on the abundance of (A) uncoupling protein-2 (UCP2), (B) glucocorticoid receptor (GR), and (C) 11ß-hydroxysteroid dehydrogenase type 2 (11ßHSD2) mRNA in fetal placentomes at 80 and 140 days gestation (dGA; term 147 dGA) from sheep that consumed 60% (nutrient restricted, NR) or 150% (control) of their metabolizable energy requirements between 28 and 80 dGA. Examples of mRNA expression are included. Values are mean with their standard errors (n = 5 per group). **P<0.01, mean value significantly different from control group at the same gestational age. Significant differences with gestational age are indicated by adjoining lines.

 

Figure 2
View larger version (8K):
[in this window]
[in a new window]

 
Figure 2 Positive relationship between uncoupling protein (UCP)-2 mRNA and glucocorticoid receptor (GR) mRNA abundance (R2 = 0.77, P<0.0001, where y = 0.80x + 0.56) inall sampled fetal placentome tissue (n = 20), irrespective of gestational age or nutritional group. Controls represented by open symbols and nutrient restricted by closed symbols; placenta sampled at 80 days gestation represented by diamonds and those sampled at 140 days gestation represented by squares.

 

Figure 3
View larger version (21K):
[in this window]
[in a new window]

 
Figure 3 Effect of early to mid-gestational maternal nutrient restriction on the abundance of insulin-like growth factor type I receptor (IGF-IR) mRNA in fetal placentomes at 80 and 140 days gestation (dGA; term 147 dGA), from sheep that consumed 60% (nutrient restricted, NR) or 150% (control) of their metabolizable energy requirements between 28 and 80 dGA. Examples of mRNA expression are included. Values are means with their standard errors (n = 5 per group). *P<0.05, mean value significantly different from control group at the same gestational age.

 
Expression patterns of PCNA were similar between groups being specifically localized within the villi and glandular epithelium (Fig. 4a and bGo). PCNA expression was, however, markedly decreased in the placenta of nutrient-restricted mothers in which it was weakly expressed in all samples compared with moderate or strong expression in all control animals. Apoptosis, as assessed by either TUNEL staining or the detection of the cleaved form of caspase 3, was unaffected by NR (C 3.6 ± 0.2; NR 3.5 ± 0.3 positive cells per 200x magnification field). Both VDAC and cytochrome c were located within the maternal uterine syncytium region of the placenta (see representative example for cytochrome c in Fig. 5Go). The abundance of neither mitochondrial protein was influenced by NR or age and mRNA expression of VDAC was similarly unaffected (data not shown).


Figure 4
View larger version (110K):
[in this window]
[in a new window]

 
Figure 4 Representative image showing reduced expression of proliferating cell nuclear antigen (PCNA) in placenta following maternal nutrient restriction between 28 and 80 days gestation. Example from either (a) control fed or (b) nutrient-restricted mother with PCNA being present within the villi and glandular epithelium at a magnification of 200x.

 

Figure 5
View larger version (100K):
[in this window]
[in a new window]

 
Figure 5 Representative image showing immunocytochemical detection of cytochrome c in the ovine sheep placenta at mid-gestation, i.e. within the maternal uterine syncytium at a magnification of 400x . Example of staining (a) with (i.e. positive) or (b) without (i.e. negative) inclusion of cytochrome c antibody.

 

    Discussion
 Top
 Abstract
 Introduction
 Results
 Discussion
 Materials and Methods
 Acknowledgements
 References
 
Our study demonstrates the complexity of placental adaptations following exposure of the mother to a period of NR extending over more than one-third of gestational length. As such, a global reduction in maternal food intake from the time of uterine attachment and continued throughout the time of maximal placental growth restricts placental size in conjunction with increased glucocorticoid action. The magnitude of these changes then alters following the restoration of the maternal diet from 80 days gestation when the normal decrease in placental mass does not occur whilst mRNA abundance for both the GR and 11ßHSD2 are increased. These placental responses appear to be mediated in part by a reduction in cell proliferation and are likely to have a pronounced effect on both nutrient supply to the fetus as well as its endocrine environment. Indeed, the enhanced placental gluco-corticoid action with NR is likely to be the mechanism by which cell proliferation is reduced (Rogatsky et al. 1997, Demasi et al. 2007). As a consequence, tissue endocrine sensitivity of the fetus and offspring are reset, particularly with respect to glucocorticoids (Whorwood et al. 2001, Gnanalingham et al. 2005a, 2005c), thereby placing them at a potentially increased risk of cardiovascular or metabolic compromise in later life. Importantly, these adaptations are greatest in the perirenal adipose tissue (which constitutes ~80% of fetal adipose tissue) and the kidney (Whorwood et al. 2001, Gnanalingham et al. 2005a), which are the two organs whose growth is increased in previously nutrient-restricted fetuses.

It is known that for adipose tissue during the period of exponential growth there is a strong correlation between total fat mass and both local glucocorticoid action and UCP2 expression (Gnanalingham et al. 2005a). In the present study on the ovine placenta, we found a positive relationship between UCP2 and GR mRNA with gestational age that is clearly not related to placental mass per se. The exact mechanisms by which both GR and UCP2 mRNA are up-regulated in the placenta remain to be established. Endocrine regulation of UCP2 during development has been most widely studied in fetal adipose tissue in which cortisol and the biologically active thyroid hormone, triiodothyronine (T3), both appear to be involved (Gnanalingham et al. 2005d). These hormones can affect local glucocorticoid action by specifically influencing the expression of GR and 11ßHSD isoforms. Indeed, regulation of fetal UCP2 mRNA by cortisol is in accord with the effects of umbilical cord occlusion which results in a precocious rise in UCP2 mRNA in the fetal lung and adipose tissue (Gnanalingham et al. 2005e). Under these adverse hypoxic conditions, however, it is cortisol, rather than T3, which regulates UCP2 abundance. In the present study, however, the endocrine mechanisms may be maternally driven as we have previously established that both maternal plasma cortisol and thyroid hormones are decreased over the period of NR (Bispham et al. 2003). It remains to be established whether these directly impact on placental glucocorticoid action and in particular increase its sensitivity to cortisol.

Interestingly, the increase in mitochondrial mRNA abundance for UCP2 was not accompanied by any change in VDAC or cytochrome c protein. This contrasts with adipose tissue in which nutritional programming of all of these proteins is observed (Mostyn et al. 2003) and emphasizes their tissue-specific regulation (Gnanalingham et al. 2005b, 2006). Unfortunately, we were unable to confirm whether UCP2 protein was similarly affected because of the current unavailability of specific antibodies for ovine UCP2 (Gnanalingham et al. 2005f). The functional consequence of an increase in placental UCP2 remains to be established. One putative role for UCP2 is in apoptosis (Voehringer et al. 2000), which, in the placenta, is determined in part by glucocorticoid sensitivity (Waddell et al. 2000). Apoptosis was, however, unaffected by NR in our study. Interestingly, we have shown for the first time that both VDAC and cytochrome c are located within the syncytial region of the placenta, which is the major site of glucose transport across the placenta (Dandrea et al. 2001). This process obviously requires appreciable amounts of energy, which will need to be met within the mitochondria, and does not appear to be impaired by reduced maternal food intake and the reduction in placental cell proliferation.

The persistent increase in placental GR mRNA abundance with maternal NR was not accompanied by a similar change in 11ßHSD2 mRNA, which was transiently decreased at 80 days, but then increased near to term. These data extend previous findings in which no effect of early to mid-gestational NR was found on 11ßHSD1 mRNA at term and a reduction in 11ßHSD2 was only present in mid-gestation (Whorwood et al. 2001). Unlike the present study that utilized RT-PCR, previous work may have been unable to detect this gene in term placenta because the less sensitive technique of Northern blotting was used (Whorwood et al. 2001). By term, the placentae of NR mothers demonstrate a marked up-regulation in 11ßHSD2 mRNA that is likely to be paralleled by an increase in 11ßHSD2 enzyme activity (Whorwood et al. 2001). The time course of this adaptation corresponds to the period in which maternal plasma cortisol adapts from being reduced during the period of NR to subsequently rising as the maternal diet is restored to the same level as controls (Bispham et al. 2003). Taken together, these findings indicate that it is not only the prevailing maternal cortisol that influences placental and, thus, fetal exposure to cortisol but it is the magnitude of change in the maternal circulation throughout pregnancy. As such, a transient rise in maternal cortisol in late gestation has no effect on fetal cortisol (Edwards & McMillen 2001). Indeed, the increase in placental 11ßHSD2 activity with gestation that only occurred in the nutrient-restricted group would be predicted to reduce fetal cortisol exposure (Langley-Evans et al. 1996). This may therefore be the mechanism by which fetal sensitivity is raised in these offspring, which is in direct contrast to the response of adipose tissue in offspring born to mothers nutrient restricted in late gestation (Gnanalingham et al. 2005a).

In contrast to the GR, mRNA abundance for the IGF-IR was decreased in placenta of NR mothers at 80, but not 140, days gestation. This coincided with the stage at which mean placentome mass was reduced and is in accord with findings in rats and humans in which intrauterine growth retardation is accompanied with reduced placental IGF-IR (Reid et al. 2002, Laviola et al. 2005). It should be noted, however, that the placenta is markedly different between sheep, rats, and humans which have discoid, hemochorial placenta, whereas in sheep placenta are cotyledonary synepitheliochorial that may represent an evolutionary development and can limit the transport of some molecules from the mother to fetus (Carter & Mess 2007). Therefore, in the sheep, restoration of the maternal diet together with the concomitant rise in maternal plasma IGF-I (Bispham et al. 2003) acts to restore placental responsiveness. At the same time, this adaptation is accompanied by a maintenance of placental mass, increased fetal length at term, and resetting of the relationship between fetal plasma IGF-I and body dimensions (Heasman et al. 2000).

In conclusion, we have shown that maternal NR targeted between the time of conceptus implantation throughout peak placental growth results in a pronounced change in local glucocorticoid action within the placenta, one consequence of which is increased UCP2 mRNA abundance. These adaptations occur in conjunction with a reduction in placental cell proliferation but in the absence of any affect on apoptosis. Changes in glucocorticoid action could then contribute to changes in cortisol exposure of the fetus, thereby, causing both immediate (Whorwood et al. 2001) and long-term changes in local glucocorticoid action and UCP2 abundance within specific offspring tissues (Gnanalingham et al. 2005a, 2005c).


    Materials and Methods
 Top
 Abstract
 Introduction
 Results
 Discussion
 Materials and Methods
 Acknowledgements
 References
 
Animals and experimental design
Twenty singleton-bearing Welsh Mountain sheep of similar age (median 3 years) and weight (36.1 ± 0.9 kg (mean ± S.E.M.)) were employed for the studies and individually housed at 28 days gestation as described previously (Bispham et al. 2003, Gnanalingham et al. 2005d). Animals were allocated to one of two nutritional groups using stratified randomization with respect to body weight. The sheep consumed either 60% (i.e. nutrient restricted, NR (n = 10)) or 150% (controls (n = 10) of their calculated metabolizable energy (ME) requirements for both the maternal maintenance and the growth of the conceptus on the basis of producing a 4.5 kg newborn at term (Agricultural Research Council 1980). Feed intakes were measured daily and animals weighed once every 2 weeks. NR animals consumed all of the feed offered, whereas those fed to appetite consumed 150% of ME requirements as not all of the hay was eaten. Food consumption between 28 and 80 days gestation was 3.2–3.8 MJ/day of ME in the NR group (~60% of ME requirements) and 8.7–9.9 MJ/day of ME in the control group, which was fed to appetite (and consumed ~ 150% of ME requirements). The amount of feed given to each mother was increased at by ~5–10% at 43 and 61 days gestation to meet the higher energy requirements associated with growth of the conceptus (Agricultural Research Council 1980). The diet comprised chopped hay (ME content: 7.91 MJ/kg dry matter, crude protein content (nitrogenx 6.25): 69 g/kg dry matter) and barley-based concentrate (ME content: 11.6 MJ/kg dry matter, crude protein content: 162 g/kg dry matter). The proportion of hay to concentrate fed was ~3:1 dry weight. All diets contained adequate minerals and vitamins. These were added separately to the diet with equal amounts provided to all sheep and thus were sufficient to fully meet their requirements. After 80 days gestation, all animals were offered sufficient feed to meet 100% of the ME requirements. These animals consumed between 6.5 and 7.5 MJ/day of ME and the amount of feed provided was increased by ~10% at 100 and 120 days gestation to meet the increased ME requirements that accompany the increase in fetal weight with gestation.

In order to determine the effect of early to mid-gestational maternal NR on fetal placentome development, five sheep within each nutrition group were randomized to tissue sampling at either 80 or 140 days gestation. Each animal was humanely euthanized following i.v. administration of 200 mg/kg pentobarbital sodium (Euthatal: RMB Animal Health, Dagenham, UK). The entire uterus was removed from each animal and a number of randomly chosen A type placentomes as determined by their visual appearance (Vatnick et al. 1991) were sampled. These represent the majority of placentomes in the sheep (Clarke et al. 1998, Heasman et al. 1998) and were immediately dissected and either put into 10% (v/v) formalin and embedded in paraffin wax for subsequent histological analysis, or separated into maternal and fetal components and immediately placed in liquid nitrogen and stored at –80 °C for later analysis. In addition, total placental and fetal weights were recorded together with all major organs. All operative procedures and experimental protocols had the required Home Office approval as designated by the Animals (Scientific Procedures) Act (1986).

Laboratory analyses
mRNA detection
Total RNA was isolated from fetal placentome tissue using Tri-Reagent (Sigma) and the expression of UCP2, GR (type 2), 11ßHSD2, and IGF-IR mRNA determined by reverse transcriptase-PCR (RT-PCR) as described previously (Bispham et al. 2003, Gnanalingham et al. 2005c). The analysis used oligonucleotide cDNA primers to UCP2, GR (type 2), 11ßHSD2, and IGF-IR genes as published previously (Bispham et al. 2003, Gnanalingham et al. 2005c), whilst VDAC expression was determined using the primers of Cesar & Wilson (2004), all generating specific intron-spanning products. Standard curves for each gene were initially established in order to optimize the amount of cDNA required for each subsequent analysis. Agarose gel electrophoresis and ethidium bromide staining confirmed the presence of both the product and the ribosomal 18S, and densitometric analysis was performed using a Fujifilm LAS-1000 cooled charge-coupled device (CCD) camera. Consistency of lane loading for each sample was verified and all results expressed as a ratio of a reference sample to r18S abundance. All analyses and gels were conducted in duplicate.

Protein detection
Mitochondria and plasma membranes were prepared from ~1 g of fetal placentome (Budge et al. 2000) and protein content determined by the Lowry method (Lowry et al. 1951). Western blotting was utilized to measure the abundance of VDAC and cytochrome c mitochondrial proteins (Mostyn et al. 2003). Identical amounts of placental protein were loaded (i.e. 10 µg) onto each gel for each sample. Following electroblotting of the polyacrylamide gel onto a nitrocellulose membrane, Ponceau red staining was used to visually confirm that similar amounts of protein had been transferred before subjecting the membranes to immunodetection (Mostyn et al. 2003). Abundance of cytochrome c was determined using a specific antibody (sc-7159; Santa Cruz, Biotechnology Inc., Santa Cruz, USA) at a dilution of 1 in 1000. VDAC abundance was determined using an antibody raised in rabbits to ovine VDAC1, purified from the kidney of a newborn sheep (Mostyn et al. 2003) at a dilution of 1 in 2000. Densitometric analysis was performed using AIDA software (Aida version 2.0; raytest Isotopenmeßgeräte GmBH Straubenhardt, Germany) on each membrane following image detection using a Fujifilm LAS-1000 cooled CCD camera (Fuji Photo Film Co. Ltd, Tokyo, Japan). All values were expressed in densitometric units. Specificity of detection was confirmed using nonimmune rabbit serum. All gels were run in duplicate and a reference sample (placental mitochondria from a control sheep sampled at 140 days gestation) was included on each to allow comparison between gels.

In addition, further Western blots were performed to confirm the effects of maternal nutrition on GR and IGF-IR protein abundance. This was undertaken using polyclonal antibodies for each protein purchased from Santa Cruz (catalogue numbers SC 8992 and 713 respectively). Each antibody was tested at a range of dilutions from 1:150 to 1:1000 under both mild reducing and nonreducing conditions using up to 80 µg protein. Unfortunately, neither antibody yielded a concise signal (in any of the animals) that was in accord with its predicted molecular mass (i.e. signals were nonspecific). Nonspecificity of detected bands was confirmed through regression analysis of molecular weight markers to determine exact size and through incubation with nonimmune rabbit serum. All Western blots were run in duplicate and included a range of molecular weight markers and a positive reference sample (plasma membranes isolated from 1-day-old sheep).

Immunohistochemistry and assessment of apoptosis
To establish the cellular location of VDAC and cytochrome c within the placenta, immunohistochemistry was performed using the antibodies described above at dilutions ranging from 1:100 to 1:1000 (Dandrea et al. 2001). Following incubation with enzyme-conjugated second antibody and chromogen substrate, sections were examined by light microscopy. The specificity of the procedure was confirmed by the absence of binding when adjacent sections were incubated with rabbit serum from an unimmunized rabbit in place of rabbit anti-ovine primary antibody. It was not possible to perform the same analyses with respect to the location of UCP2 due to the lack of appropriately validated antibodies (Gnanalingham et al. 2005f). The same analyses were undertaken for the GR and IGF-IR, but in accord with our failure to detect protein at the correct molecular weight by Western blotting neither antibody showed specificity of binding to the placenta. This procedure was undertaken on 20–30 randomly selected sections from each nutritional group.

Measurement of cell proliferation within the placenta was also undertaken by determining the amount of immunoreactive proliferating cell nuclear antigen (PCNA) expression (Waseem & Lane 1990). This was undertaken using a mouse MAB to PCNA (PC10) (Alexis Biochemicals, Bingham, Nottingham) at a 1:200 dilution. Relative staining intensity for immunoreactive nuclear PCNA expression was visually assessed in a blinded manner and scored as either absent (–; no nuclear staining), weak ( +), moderate ( + +), or strong ( + + +) (Taylor et al. 2000). Immunohistochemistry was performed on a computerized Bond automated immunohistochemistry system (Vision Biosystems Limited, Newcastle-upon-Tyne, UK) using a bond polymer refine detection kit. A negative control was performed for each test section by omitting incubation in the primary antibody. Tonsil, in which PCNA staining is pronounced, was used as the positive control (Waseem & Lane 1990). Sections were dehydrated in ascending concentrations of alcohol and xylene before coverslips were mounted.

These sections were also used to assess the relative incidence of apoptosis by the TUNEL assay (Roche Diagnostics; Gavrieli et al. 1992). Sections were stored at 4 °C in the dark and the magnitude of staining analyzed within 48 h. Appropriate negative controls were included to assess both nonspecific binding and the extent of autofluorescence. Positive controls were treated with DNase type I to produce fragmentation of chromosomal DNA and washed separately to prevent any residual DNase activity affecting other sections. All analyses were performed using the same assessor who was blinded to nutritional grouping using reference slides to check consistency of grading assessment. To assess the relative incidence of apoptosis between groups, slides were analyzed using fluorescence microscopy with FITC and u.v. filters to visualize green (fragmented DNA) and a semi-quantitative apoptosis index (0–4; Lepault et al. 2005) used. This procedure was undertaken on 30 randomly selected sections from each nutritional group at a magnification of 200x . In addition, as the TUNEL reaction is unable to discriminate apoptotic from necrotic cells, caspase-3, a marker of early apoptosis (Gown & Willingham 2002) was localized using a rabbit anti-caspase 3 polyclonal antibody (Abcam plc, Cambridge, UK) diluted 1:50. Immunohistochemistry was performed using the Bond automated system with a bond polymer refine detection kit (Vision Biosystems Limited). A negative control was performed for each test section by omitting incubation in the primary antibody. Tonsil, in which apoptosis is pronounced, was used as the positive control (Krajewska et al. 1997). For each section, the number of positive cells in five randomly selected fields was used to calculate the mean positive cell count ± S.E.M per 200x field.

Statistical analysis
All data are presented as the means ± S.E.M. Significant differences (P<0.05) between gestational ages and nutritional groups were analyzed by ANOVA. Significant correlations between molecular parameters were assessed by Spearman’s Rank Order Test (SPSS v11.0; SPSS Inc., Chicago, Illinois, USA).


    Acknowledgements
 Top
 Abstract
 Introduction
 Results
 Discussion
 Materials and Methods
 Acknowledgements
 References
 
This work was funded by the Special Trustees of Nottingham University Hospitals, the British Heart Foundation Lectureship, and the European Union Sixth Framework Programme for Research and Technical Development of the European Community – The Early Nutrition Programming Project (FOOD-CT-2005-007036). The authors declare that there is no conflict of interest that would prejudice the impartiality of this scientific work.


    Footnotes
 
Received 14 December 2006
First decision 26 January 2007
Revised manuscript received 26 June 2007
Accepted 13 July 2007


    References
 Top
 Abstract
 Introduction
 Results
 Discussion
 Materials and Methods
 Acknowledgements
 References
 

Agricultural Research Council 1980 Requirements for energy, The Nutritional Requirements of Ruminant Livestock, Slough, UK: Commonwealth Agricultural Bureau.

Bamberger CM, Schulte HM & Chrousos GP 1996 Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids. Endocrinology Reviews 17 245–261.[Abstract/Free Full Text]

Barker DJP 2001 The malnourished baby and infant. British Medical Bulletin 60 69–88.[Abstract/Free Full Text]

Bispham J, Gopalakrishnan GS, Dandrea J, Wilson V, Budge H, Keisler DH, Broughton Pipkin F, Stephenson T & Symonds ME 2003 Maternal endocrine adaptation throughout pregnancy to nutritional manipulation: consequences for maternal plasma leptin and cortisol and the programming of fetal adipose tissue development. Endocrinology 144 3575–3585.[Abstract/Free Full Text]

Budge H, Bispham J, Dandrea J, Evans E, Heasman L, Ingleton PM, Sullivan C, Wilson V, Stephenson T & Symonds ME 2000 Effect of maternal nutrition on brown adipose tissue and its prolactin receptor status in the fetal lamb. Pediatric Research 47 781–786.[Web of Science][Medline]

Carter AM & Mess A 2007 Evolution of the placenta in Eutherian mammals. Placenta 28 295–262.

Cesar MC & Wilson JE 2004 All three isoforms of the voltage-dependent anion channel (VDAC1, VDAC2, and VDAC3) are present in mitochondria from bovine, rabbit, and rat brain. Archives of Biochemistry and Biophysics 422 191–196.[CrossRef][Web of Science][Medline]

Clarke L, Heasman L, Juniper DT & Symonds ME 1998 Maternal nutrition in early-mid gestation and placental size in sheep. British Journal of Nutrition 79 359–364.[CrossRef][Web of Science][Medline]

Colombini M 1979 A candidate for the permeability pathway of the outer mitochondrial membrane. Nature 279 643–645.[CrossRef][Medline]

Crompton M 1999 The mitochondrial permeability transition pore and its role in cell death. Biochemical Journal 341 233–249.[CrossRef][Web of Science][Medline]

Dandrea J, Wilson V, Gopalakrishnan G, Heasman L, Budge H, Stephenson T & Symonds ME 2001 Maternal nutritional manipulation of placental growth and glucose transporter-1 abundance in sheep. Reproduction 122 793–800.[Abstract]

Demasi MA, Montor WR, Ferreira GB, Pimenta DC, Labriola L & Sogayar MC 2007 Differential proteomic analysis of the anti-proliferative effect of glucocorticoid hormones in ST1 rat glioma cells. Journal of Steroid Biochemistry Molecular Biology 103 137–148.[CrossRef][Web of Science][Medline]

Edwards LJ & McMillen IC 2001 Maternal undernutrition increases arterial blood pressure in the sheep fetus during late gestation. Journal of Physiology 533 561–570.[Abstract/Free Full Text]

Ehrhardt RA & Bell AW 1995 Growth and metabolism of the ovine placenta during mid-gestation. Placenta 16 727–741.[CrossRef][Web of Science][Medline]

Gavrieli Y, Sherman Y & Ben-Sasson SA 1992 Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. Journal of Cell Biology 119 493–501.[Abstract/Free Full Text]

Gnanalingham MG, Mostyn A, Symonds ME & Stephenson T 2005a Ontogeny and nutritional programming of adiposity: potential role of glucocorticoid sensitivity and uncoupling protein-2. American Journal of Physiology 289 R1407–R1415.[Web of Science]

Gnanalingham MG, Mostyn A, Gardner DS, Stephenson T & Symonds ME 2005b Developmental regulation of adipose tissue: nutritional manipulation of local glucocorticoid action and uncoupling protein 2. Adipocytes 1 221–228.

Gnanalingham MG, Mostyn A, Dandrea J, Yakubu DP, Symonds ME & Stephenson T 2005c Ontogeny and nutritional programming of uncoupling protein-2 and glucocorticoid receptor mRNA in the ovine lung. Journal of Physiology 565 159–169.[Abstract/Free Full Text]

Gnanalingham MG, Mostyn A, Forehead AJ, Fowden AL, Symonds ME & Stephenson T 2005d Increased uncoupling protein-2 mRNA abundance and glucocorticoid sensitivity in adipose tissue in the sheep fetus during late gestation is dependent on plasma cortisol and triiodothyronine. Journal of Physiology 567 283–292.[Abstract/Free Full Text]

Gnanalingham MG, Giussani DA, Sivathondan P, Forehead AJ, Stephenson T, Symonds ME & Gardner DS 2005e Chronic umbilical cord compression results in premature maturation of lung and brown adipose tissue in the late gestation ovine fetus. American Journal of Physiology 289 E456–E465.[Web of Science]

Gnanalingham MG, Mostyn A, Webb R, Keisler DH, Raver N, Alves-Guerra MC, Pecqueur C, Miroux B, Symonds ME & Stephenson T 2005f Differential effects of leptin administration on the abundance of uncoupling protein-2 and glucocorticoid action during neonatal development. American Journal of Physiology 289 E1093–E1100.[Web of Science]

Gnanalingham MG, Mostyn A, Gardner DS, Stephenson T & Symonds ME 2006 Developmental regulation of the lung in preparation for life after birth: nutritional manipulation of local glucocorticoid action and uncoupling protein 2. Journal of Endocrinology 188 375–386.[Abstract/Free Full Text]

Gown AM & Willingham MC 2002 Improved detection of apoptotic cells in archival paraffin sections: immunohistochemistry using antibodies to cleaved caspase 3. Journal of Histochemistry and Cytochemistry 50 449–454.[Abstract/Free Full Text]

Heasman L, Clarke L, Firth K, Stephenson T & Symonds ME 1998 Influence of restricted maternal nutrition in early to mid gestation on placental and fetal development at term in sheep. Pediatric Research 44 546–551.[Web of Science][Medline]

Heasman L, Brameld JM, Mostyn A, Budge H, Dawson J, Buttery PJ, Stephenson T & Symonds ME 2000 Maternal nutrient restriction during early to mid gestation alters the relationship between IGF-I and body size at term in fetal sheep. Reproduction, Fertility and Development 12 345–350.[CrossRef][Medline]

Huppertz B & Herrler A 2005 Regulation of proliferation and apoptosis during development of the preimplantation embryo and the placenta. Birth Defects Research. Part C, Embryo Today: Reviews 75 249–261.[CrossRef]

Krajewska M, Wang HG, Krajewski S, Zapata JM, Shabaik A, Gascoyne R & Reed JC 1997 Immunohistochemical analysis of in vivo patterns of expression of CPP32 (Caspase-3), a cell death protease. Cancer Research 57 1605–1613.[Abstract/Free Full Text]

Langley-Evans SC, Phillips GJ, Benediktsson R, Gardner DS, Edwards CR, Jackson AA & Seckl JR 1996 Protein intake in pregnancy, placental glucocorticoid metabolism and the programming of hypertension in the rat. Placenta 17 169–172.[Web of Science][Medline]

Laviola L, Perrini S, Belsanti G, Natalicchio A, Montrone C, Leonardini A, Vimercati A, Scioscia M, Selvaggi L, Giorgino R, et al. 2005 Intrauterine growth restriction in humans is associated with abnormalities in placental insulin-like growth factor signaling. Endocrinology 146 1498–1505.[Abstract/Free Full Text]

Lepault E, Celeste C, Dore M, Martineau D & Theoret CL 2005 Comparative study on microvascular occlusion and apoptosis in body and limb wounds in the horse. Wound Repair and Regeneration 13 520–529.[CrossRef][Web of Science][Medline]

Lowry OH, Rosenbrough NJ, Farr AL & Randall RJ 1951 Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 193 265–275.[Free Full Text]

McMillen IC & Robinson JS 2005 Developmental origins of the metabolic syndrome: prediction, plasticity, and programming. Physiological Reviews 85 571–633.[Abstract/Free Full Text]

Mostyn A, Wilson V, Dandrea J, Yakubu DP, Budge H, Alves-Guerra MC, Pecqueur C, Miroux B, Symonds ME & Stephenson T 2003 Ontogeny and nutritional manipulation of mitochondrial protein abundance in adipose tissue and the lungs of postnatal sheep. British Journal of Nutrition 90 323–328.[CrossRef][Web of Science][Medline]

Pecquer C, Alves-Guerra M-C, Gelly C, Lévi-Meyrueis C, Couplan E, Collins S, Ricquier D, Bouillaud F & Miroux B 2001 Uncoupling protein-2: in vivo distribution, induction upon oxidative stress and evidence for translational regulation. Journal of Biological Chemistry 276 8705–8712.[Abstract/Free Full Text]

Reid GJ, Flozak AS & Simmons RA 2002 Placental expression of insulin-like growth factor receptor-1 and insulin receptor in the growth-restricted fetal rat. Journal of the Society for Gynecologic Investigations 9 210–214.[CrossRef]

Rogatsky I, Trowbridge JM & Garabedian MJ 1997 Glucocorticoid receptor-mediated cell cycle arrest is achieved through distinct cell-specific transcriptional regulatory mechanisms. Molecular Cell Biology 17 3181–3193.[Abstract/Free Full Text]

Rousset S, Alves-Guerra M-C, Ouadghiri-Bencherif S, Kozak LP, Miroux B, Richard D, Bouillaud F, Ricquier D & Cassard-Doulcier A-M 2003 UCP2 is expressed in the female mice reproductive tract whereas UCP1 is not. Journal of Biological Chemistry 278 45843–45847.[Abstract/Free Full Text]

Stegmann JHJ 1974 Placental development in sheep. Bijdragen tot de Dierkunde 44 4–72.

Stewart PM & Krozowski ZS 1999 11b-Hydroxysteroid dehydrogenase. Vitamins and Hormones 57 249–324.[Web of Science][Medline]

Stuart JA, Harper JA, Brindle KM, Jekabsons MB & Brand MD 2001 Physiological levels of mammalian uncoupling protein 2 do not uncouple yeast mitochondria. Journal of Biological Chemistry 276 18633–18639.[Abstract/Free Full Text]

Symonds ME, Budge H, Stephenson T & Gardner DS 2005 Leptin, fetal nutrition and long term outcomes for adult hypertension. Endothelium 12 73–79.[CrossRef][Web of Science][Medline]

Symonds ME, Budge H, Mostyn A, Stephenson T & Gardner DS 2007 Maternal diet through pregnancy – the key to future good health of the next generation. In Reducing Diets: New research, Ed. SV Watkins. New York: Nova Science Publishers, Inc.

Taylor KM, Gray CA, Joyce MM, Stewart MD, Bazer FW & Spencer TE 2000 Neonatal ovine uterine development involves alterations in expression of receptors for estrogen, progesterone, and prolactin. Biology of Reproduction 63 1192–1204.[Abstract/Free Full Text]

Vatnick I, Schoknecht PA, Darrigrand R & Bell AW 1991 Growth and metabolism of the placenta after unilateral fetectomy in twin pregnant ewes. Journal of Developmental Physiology 15 351–356.[Web of Science][Medline]

Voehringer DW, Hirschberg DL, Xiao J, Lu Q, Roederer M, Lock CB, Herzenberg LA, Steinman L & Herzenberg LA 2000 Gene microarray identification of redox and mitochondrial elements that control resistance or sensitivity to apoptosis. PNAS 97 2680–2685.[Abstract/Free Full Text]

Waddell BJ, Hisheh S, Dharmarajan AM & Burton PJ 2000 Apoptosis in rat placenta is zone-dependent and stimulated by glucocorticoids. Biology of Reproduction 63 1913–1917.[Abstract/Free Full Text]

Waseem NH & Lane DP 1990 Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA). Structural conservation and the detection of a nucleolar form. Journal of Cell Science 96 121–129.[Abstract/Free Full Text]

Whorwood CB, Firth KM, Budge H & Symonds ME 2001 Maternal undernutrition during early- to mid-gestation programmes tissue-specific alterations in the expression of the glucocorticoid receptor, 11b-hydroxysteroid dehydrogenase isoforms and type 1 angiotensin II receptor in neonatal sheep. Endocrinology 142 2854–2864.[Abstract/Free Full Text]


This article has been cited by other articles:


Home page
ReproductionHome page
S P Sebert, M A Hyatt, L L Y Chan, M Yiallourides, H P Fainberg, N Patel, D Sharkey, T Stephenson, S M Rhind, R C Bell, et al.
Influence of prenatal nutrition and obesity on tissue specific fat mass and obesity-associated (FTO) gene expression
Reproduction, January 1, 2010; 139(1): 265 - 274.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
M Yiallourides, S P Sebert, V Wilson, D Sharkey, S M Rhind, M E Symonds, and H Budge
The differential effects of the timing of maternal nutrient restriction in the ovine placenta on glucocorticoid sensitivity, uncoupling protein 2, peroxisome proliferator-activated receptor-{gamma} and cell proliferation
Reproduction, September 1, 2009; 138(3): 601 - 608.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
D P Yakubu, A Mostyn, M A Hyatt, L O Kurlak, H Budge, T Stephenson, and M E Symonds
Ontogeny and nutritional programming of mitochondrial proteins in the ovine kidney, liver and lung
Reproduction, December 1, 2007; 134(6): 823 - 830.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gnanalingham, M G
Right arrow Articles by Symonds, M E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gnanalingham, M G
Right arrow Articles by Symonds, M E


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS